Mark Alan Smith - Jun 30, 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 30, 2021
Transactions value $
$4,399
Form type
4
Date filed
7/2/2021, 04:11 PM
Next filing
Jan 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $4.4K +2.26K +22.6% $1.95 12.3K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).